Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph C Walsh

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2013
Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteersMohan Doss, Hartmuth C Kolb, Joseph C Walsh, et al.
EJNMMI Radiopharmacy and Chemistry|August 14, 2018
Synthesis, radiosynthesis, in vitro and first in vivo evaluation of a new matrix metalloproteinase inhibitor based on γ-fluorinated α-sulfonylaminohydroxamic acidVerena Hugenberg, Malte Behrends, Stefan Wagner, et al.
Molecular Imaging and Biology|April 4, 2014
Biodistribution and radiation dosimetry of the carbonic anhydrase IX imaging agent [(18) F]VM4-037 determined from PET/CT scans in healthy volunteersMohan Doss, Hartmuth C Kolb, Joseph C Walsh, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 15, 2014
Atherosclerotic plaque uptake of a novel integrin tracer ¹⁸F-Flotegatide in a mouse model of atherosclerosisHelen Su, Natalia Gorodny, Luis Felipe Gomez, et al.
Journal of Alzheimer'S Disease : JAD|August 17, 2013
Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808David T Chien, A Katrin Szardenings, Shadfar Bahri, et al.
Molecular Imaging and Biology|May 18, 2013
Evaluation of [(18)F]-CP18 as a PET imaging tracer for apoptosisHelen Su, Gang Chen, Umesh Gangadharmath, et al.
Nuclear Medicine and Biology|May 16, 2016
Radiolabeled hydroxamate-based matrix metalloproteinase inhibitors: How chemical modifications affect pharmacokinetics and metabolic stabilityVerena Hugenberg, Sven Hermann, Fabian Galla, et al.
Molecular Imaging and Biology|May 22, 2013
In vitro and in vivo evaluation of the caspase-3 substrate-based radiotracer [(18)F]-CP18 for PET imaging of apoptosis in tumorsChun-Fang Xia, Gang Chen, Umesh Gangadharmath, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 14, 2012
Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humansMohan Doss, Hartmuth C Kolb, James J Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2011
Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imagingLudwig J Dubois, Natasja G Lieuwes, Marco H M Janssen, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2013
Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteersMohan Doss, Hartmuth C Kolb, Joseph C Walsh, et al.
EJNMMI Radiopharmacy and Chemistry|August 14, 2018
Synthesis, radiosynthesis, in vitro and first in vivo evaluation of a new matrix metalloproteinase inhibitor based on γ-fluorinated α-sulfonylaminohydroxamic acidVerena Hugenberg, Malte Behrends, Stefan Wagner, et al.
Molecular Imaging and Biology|April 4, 2014
Biodistribution and radiation dosimetry of the carbonic anhydrase IX imaging agent [(18) F]VM4-037 determined from PET/CT scans in healthy volunteersMohan Doss, Hartmuth C Kolb, Joseph C Walsh, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 15, 2014
Atherosclerotic plaque uptake of a novel integrin tracer ¹⁸F-Flotegatide in a mouse model of atherosclerosisHelen Su, Natalia Gorodny, Luis Felipe Gomez, et al.
Journal of Alzheimer'S Disease : JAD|August 17, 2013
Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808David T Chien, A Katrin Szardenings, Shadfar Bahri, et al.
Molecular Imaging and Biology|May 18, 2013
Evaluation of [(18)F]-CP18 as a PET imaging tracer for apoptosisHelen Su, Gang Chen, Umesh Gangadharmath, et al.
Nuclear Medicine and Biology|May 16, 2016
Radiolabeled hydroxamate-based matrix metalloproteinase inhibitors: How chemical modifications affect pharmacokinetics and metabolic stabilityVerena Hugenberg, Sven Hermann, Fabian Galla, et al.
Molecular Imaging and Biology|May 22, 2013
In vitro and in vivo evaluation of the caspase-3 substrate-based radiotracer [(18)F]-CP18 for PET imaging of apoptosis in tumorsChun-Fang Xia, Gang Chen, Umesh Gangadharmath, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 14, 2012
Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humansMohan Doss, Hartmuth C Kolb, James J Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2011
Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imagingLudwig J Dubois, Natasja G Lieuwes, Marco H M Janssen, et al.
Pageof 3